Press Releases

STAINES-UPON-THAMES, United Kingdom, Aug. 6, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today reported results fo

Read more...

BATON ROUGE, La., Aug. 6, 2019 /PRNewswire/ -- GB Sciences Louisiana (OTCQB: GBLX) today announced that its medical cannabis products, developed in partnership with LSU AgCenter's Therapeutic Cannabis Program, are available for sale to qualified patients in the state's nine licensed pharmacies. This is the first time that qualified patients have legal can

Read more...

HOLON, Israel, Aug. 6, 2019 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) and (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced that

Read more...

LINCOLN, Neb., Aug. 6, 2019 /PRNewswire/ -- Researchers can identify therapeutic targets and functional effects of targeted therapeutics more quickly and efficiently as part of a complete solution now offered by LI-COR Biosciences in partnership with NMI TT Pharmaservices. DigiWest High-Content Protein Profiling Services speed the process of developing relevant the

Read more...

Leading Provider of Class IV Lasers Becomes Summus Medical Laser™; Offers Advanced Technology for Practice Management FRANKLIN, Tenn., Aug. 6, 2019 /PRNewswire/ -- K-Laser USA Founder and CEO Dr. Richard Albright announced today the new company name, Summus Medical Laser, in a strategic initia

Read more...

SAN RAFAEL, Calif., Aug. 6, 2019 /PRNewswire/ -- Autodesk, Inc. (NASDAQ: ADSK) today announced

Read more...

SAN RAMON, Calif., Aug. 6, 2019 /PRNewswire/ -- BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced two sign

Read more...

LINKÖPING, Sweden, Aug. 6, 2019 /PRNewswire/ -- The shareholders of the medical imaging IT and cyber security company Sectra AB (publ) are hereby invited to the Annual General Meeting ("AGM") held on Thursday, September 5, 2019 at 3.30 p.m. (CET) at Collegium, Teknikringen 7, Linköping,

Read more...

VANCOUVER, British Columbia, Aug. 6, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM.CN) (CSE: MYM) (OTCBB: MYMMF) ("MYM Nutraceuticals" or the "Company") is pleased to announce the incorporation of MYM International Brands Inc. ("MYM International Brands") to focus on the growing global demand for CBD-rich consumer products. The passing of the

Read more...

TARRYTOWN, N.Y. and PARIS, Aug. 6, 2019 /PRNewswire/ -- U.S. FDA submission for children planned for 4Q 2019Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat severe atopic dermatitis in children aged 6 to 11

Read more...